Logo image of IVCP

SWIFTMERGE ACQUISITION COR-A (IVCP) Stock Fundamental Analysis

NASDAQ:IVCP - Nasdaq - KYG638361033 - Common Stock - Currency: USD

10.5  +0.99 (+10.41%)

After market: 10.55 +0.05 (+0.48%)

Fundamental Rating

1

Overall IVCP gets a fundamental rating of 1 out of 10. We evaluated IVCP against 0 industry peers in the Unkown industry. IVCP may be in some trouble as it scores bad on both profitability and health. IVCP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IVCP had negative earnings in the past year.
In the past year IVCP has reported a negative cash flow from operations.
IVCP Yearly Net Income VS EBIT VS OCF VS FCFIVCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M

1.2 Ratios

Industry RankSector Rank
ROA -0.28%
ROE -0.4%
ROIC N/A
ROA(3y)4.78%
ROA(5y)N/A
ROE(3y)5.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVCP Yearly ROA, ROE, ROICIVCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 5 -5 10 -10 15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IVCP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IVCP Yearly Profit, Operating, Gross MarginsIVCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for IVCP has been reduced compared to 1 year ago.
IVCP has a worse debt/assets ratio than last year.
IVCP Yearly Shares OutstandingIVCP Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
IVCP Yearly Total Debt VS Total AssetsIVCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 99.56 indicates that IVCP is not in any danger for bankruptcy at the moment.
IVCP has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 99.56
ROIC/WACCN/A
WACCN/A
IVCP Yearly LT Debt VS Equity VS FCFIVCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

IVCP has a Current Ratio of 0.01. This is a bad value and indicates that IVCP is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.01 indicates that IVCP may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
IVCP Yearly Current Assets VS Current LiabilitesIVCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

IVCP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -110.28%.
EPS 1Y (TTM)-110.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-124.37%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

IVCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVCP Price Earnings VS Forward Price EarningsIVCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVCP Per share dataIVCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVCP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SWIFTMERGE ACQUISITION COR-A

NASDAQ:IVCP (12/13/2024, 8:00:02 PM)

After market: 10.55 +0.05 (+0.48%)

10.5

+0.99 (+10.41%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners25.25%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap710.96M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 74.8
P/tB 74.8
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.28%
ROE -0.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.78%
ROA(5y)N/A
ROE(3y)5.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 99.56
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-110.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-124.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.84%
OCF growth 3YN/A
OCF growth 5YN/A